Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lornoxicam 4mg tablets
1001010AIAAABAB
|
Lornoxicam | Lornoxicam | Musculoskeletal and Joint Diseases | No data available |
|
Lornoxicam 8mg tablets
1001010AIAAACAC
|
Lornoxicam | Lornoxicam | Musculoskeletal and Joint Diseases | No data available |
|
Xefo 4mg tablets
1001010AIBBABAB
|
Xefo | Lornoxicam | Musculoskeletal and Joint Diseases | No data available |
|
Xefo 8mg tablets
1001010AIBBACAC
|
Xefo | Lornoxicam | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.